PLZF and its fusion proteins are pomalidomide-dependent CRBN neosubstrates

Shimizu et al. identify PLZF/ZBTB16 and its fusion proteins as pomalidomide-dependent neosubstrates of the cereblon E3 ligase. The authors also report that pomalidomide induces their degradation and thereby exerts its anti-cancer effect in leukemic cells expressing the fusion proteins.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nobuyuki Shimizu, Tomoko Asatsuma-Okumura, Junichi Yamamoto, Yuki Yamaguchi, Hiroshi Handa, Takumi Ito
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Accès en ligne:https://doaj.org/article/8e042573d7f949a6bd3a74bcd451d1ff
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!